Department of Ophthalmology Aarhus Sygehus - Aarhus University Hospital, Denmark
Aarhus, 8000, Denmark
NCT Number: NCT01673503
The purpose of this study is to compare visual acuity, safety, predictability, corneal biomechanics, dry eyes, and nerve-morphology after all femtosecond laser refractive lenticule extraction. Approximately 30 to 40 patients with moderate to high myopia will randomly (after ocular dominance) receive ReLEx flex in one eye, and ReLEx smile in the other.
Looking for future studies?
Notify Me25 year–45 year
All sexes
Interventional
Phase 3
Aarhus, 8000, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Refractive lenticule extraction (ReLEx) with the Carl Zeiss Meditech VisuMax laser
Other names: Refractive lenticule extraction, ReLEx
Time frame: up to 6 months
Using ETDRS charts, both uncorrected and corrected distance visual acuity, along with visual acuity using the FrACT contrast chart
Time frame: Pre-surgery, 1 week, 1 month, 3 months, 6 months
Optometrists measure refraction at follow-up-examinations, and the refraction 6 monhts after surgery will be compared to the target refraction to calculate refractive predictability
Time frame: pre-surgery and 6 months after
Corneal hysteresis and corneal resistence factor using the Ocular response analyser, nerve changes using the Cochet-Bonnet Aesthesiometer and confokal mikroscopy, and dry eyes symptoms using Schirmers test, Tear BUT, and Oculus keratograph, along with anterior segment OCT to measure tear meniscus hight.
Odense University Hospital
Other
A Prospective Study of Femtosecond Laser Intracorneal Lensectomi in Treatment of Moderate to High Myopia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06873048
Astigmatism, Eye Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT04200898
Astigmatism, Eye Diseases
Zagreb, City of Zagreb, Croatia
View Trial DetailsNCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsNCT05740293
Astigmatism, Eye Diseases
Fayetteville, Arkansas, United States
View Trial Details